Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Òscar Domènech"'
Autor:
Negar Beirampour, Paola Bustos-Salgado, Núria Garrós, Roya Mohammadi-Meyabadi, Òscar Domènech, Joaquim Suñer-Carbó, María José Rodríguez-Lagunas, Garyfallia Kapravelou, María Jesús Montes, Ana Calpena, Mireia Mallandrich
Publikováno v:
Pharmaceutics, Vol 16, Iss 8, p 1092 (2024)
Topical ocular drug delivery faces several challenges due to the eye’s unique anatomy and physiology. Physiological barriers, tear turnover, and blinking hinder the penetration of drugs through the ocular mucosa. In this context, nanoparticles offe
Externí odkaz:
https://doaj.org/article/9b7f11bde2cd442da8ff3f03e5fe7117
Autor:
Núria Garrós, Paola Bustos-Salgados, Òscar Domènech, María José Rodríguez-Lagunas, Negar Beirampour, Roya Mohammadi-Meyabadi, Mireia Mallandrich, Ana C. Calpena, Helena Colom
Publikováno v:
Pharmaceuticals, Vol 16, Iss 6, p 894 (2023)
Atopic dermatitis (AD) is a chronic autoimmune inflammatory skin disorder which causes a significant clinical problem due to its prevalence. The ongoing treatment for AD is aimed at improving the patient’s quality of life. Additionally, glucocortic
Externí odkaz:
https://doaj.org/article/f52ad5d89c9045a4a7eeca86f99d4b1a
Autor:
Isabel Pérez-Guillén, Òscar Domènech, Adrià Botet-Carreras, Alexandra Merlos, Josep M. Sierra, Fernando Albericio, Beatriz G. de la Torre, M. Teresa Montero, Miguel Viñas, Jordi H. Borrell
Publikováno v:
Pharmaceutics, Vol 14, Iss 10, p 2191 (2022)
The super-cationic peptide dendrimers (SCPD) family is a valuable class of antimicrobial peptide candidates for the future development of antibacterial agents against multidrug-resistant gram-negative bacteria. The deep knowledge of their mechanism o
Externí odkaz:
https://doaj.org/article/432929c77f2d4eea86c94bca7b5262f1
Autor:
Núria Garrós, Mireia Mallandrich, Negar Beirampour, Roya Mohammadi, Òscar Domènech, Maria José Rodríguez-Lagunas, Beatriz Clares, Helena Colom
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1895 (2022)
Sjögren’s syndrome is a chronic systemic autoimmune disease affecting from 0.2 to 3% of the general population. The current treatment for Sjögren’s syndrome is aimed at controlling symptoms such as dry eyes and xerostomia. Systemic therapy with
Externí odkaz:
https://doaj.org/article/073c6039f82948ccb88feef9595e3697
Autor:
José L. Soriano, Ana C. Calpena, María J. Rodríguez-Lagunas, Òscar Domènech, Nuria Bozal-de Febrer, María L. Garduño-Ramírez, Beatriz Clares
Publikováno v:
Pharmaceutics, Vol 13, Iss 1, p 8 (2020)
The main goal of this work is the study of the skin wound healing efficacy of an antioxidant cocktail consisting of vitamins A, D, E and the endogenous pineal hormone melatonin (MLT), with all of these loaded into a thermosensitive hydrogel delivery
Externí odkaz:
https://doaj.org/article/370fc064c74447f7895080143a6a5538
Autor:
Lupe Carolina Espinoza, Rodrigo Vera-García, Marcelle Silva-Abreu, Òscar Domènech, Josefa Badia, María J. Rodríguez-Lagunas, Beatriz Clares, Ana Cristina Calpena
Publikováno v:
Pharmaceutics, Vol 12, Iss 3, p 255 (2020)
Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show additional therapeutic activities on diverse inflammatory parameters. The aim of this study was to optimize a topical PGZ-loaded nanoemulsion (PGZ-NE)
Externí odkaz:
https://doaj.org/article/7ad156f428b449d78b20f0d638e51966
Autor:
Colom, Núria Garrós, Paola Bustos-Salgados, Òscar Domènech, María José Rodríguez-Lagunas, Negar Beirampour, Roya Mohammadi-Meyabadi, Mireia Mallandrich, Ana C. Calpena, Helena
Publikováno v:
Pharmaceuticals; Volume 16; Issue 6; Pages: 894
Atopic dermatitis (AD) is a chronic autoimmune inflammatory skin disorder which causes a significant clinical problem due to its prevalence. The ongoing treatment for AD is aimed at improving the patient’s quality of life. Additionally, glucocortic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::4b87b5f8dd583490120a789309bbfab3
Autor:
Adrià, Botet-Carreras, Manel Bosch, Marimon, Ruben, Millan-Solsona, Eva, Aubets, Carlos J, Ciudad, Véronique, Noé, M Teresa, Montero, Òscar, Domènech, Jordi H, Borrell
In this study, we assessed the capacity of a previously reported engineered liposomal formulation, which had been tested against model membranes mimicking the lipid composition of the HeLa plasma membrane, to fuse and function as a nanocarrier in cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::910e8c078dc55da47c477c6235dad839
http://hdl.handle.net/2445/198462
http://hdl.handle.net/2445/198462
Autor:
Colom, Núria Garrós, Mireia Mallandrich, Negar Beirampour, Roya Mohammadi, Òscar Domènech, Maria José Rodríguez-Lagunas, Beatriz Clares, Helena
Publikováno v:
Pharmaceutics; Volume 14; Issue 9; Pages: 1895
Sjögren’s syndrome is a chronic systemic autoimmune disease affecting from 0.2 to 3% of the general population. The current treatment for Sjögren’s syndrome is aimed at controlling symptoms such as dry eyes and xerostomia. Systemic therapy with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::65d9220bac27955ba9e6dc6eea35feea
Autor:
Esther Miralles, Christina S. Kamma-Lorger, Òscar Domènech, Lilian Sosa, Isidre Casals, Ana Cristina Calpena, Marcelle Silva-Abreu
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 11184
Drug-loaded nanocarriers (NCs) are new systems that can greatly improve the delivery and targeting of drugs to specific tissues and organs. In our work, a PPAR-γ agonist loaded into polymeric NCs was prepared, stabilized by spray-drying, and tested
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d220a66af67494c515b61f93f63b34
https://pubmed.ncbi.nlm.nih.gov/36232486
https://pubmed.ncbi.nlm.nih.gov/36232486